Open AccessConcurrent EGFR mutation and ALK rearrangement in stage IV lung adenocarcinoma—a case report and a literature review
Author(s) -
Élia Cipriano,
Helena Magalhães,
Catarina Tavares,
João Pinto,
Luı́s Cirnes,
F. Estevinho
Publication year - 2021
Publication title -
porto biomedical journal/porto biomedical journal
Language(s) - English
Resource type - Journals
eISSN - 2444-8672
pISSN - 2444-8664
DOI - 10.1097/j.pbj.0000000000000124
Subject(s) - anaplastic lymphoma kinase , gefitinib , adenocarcinoma , lung cancer , medicine , cancer research , epidermal growth factor receptor , oncology , mutation , crizotinib , malignancy , targeted therapy , population , cancer , biology , gene , genetics , environmental health , malignant pleural effusion